EQT

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.

Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.

Egle Therapeutics SAS is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing innovative immunotherapies that target immune suppressor regulatory T-cells (Tregs) for the treatment of oncology and autoimmune diseases. The company's research focuses on a proprietary drug pipeline that includes computationally designed IL-2 variants aimed at modulating Treg activity. This approach seeks to either engage or dis-engage Tregs, facilitating the development of therapies that can effectively combat cancer and other related conditions by addressing the immune suppression caused by Tregs. Egle Therapeutics aims to advance its unique portfolio to provide new treatment options in the healthcare field.

They are the largest independent MGA in the UK. They provide their insurance products exclusively through authorised insurance brokers in over 60 countries around the world. Wholesale or retail, big or small, generalist or specialist, all of their brokers have access to underwriters who can make fast decisions and provide flexible solutions. By providing market-leading products, great service and configurable online systems, they help their brokers carry out business more easily, efficiently and profitably. That’s probably why they’ve won eight major industry awards in the last year and over 1,500 businesses move their insurance to CFC every month.

Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to a diverse range of titles across more than 20 markets. Founded in 2005 and headquartered in Sweden, the company operates under the Storytel and Mofibo brands, providing users with the ability to explore a wide array of genres, including detective stories, novels, and biographies, in multiple languages such as Swedish, English, Arabic, Danish, and Finnish. Storytel also has a significant publishing division that includes several established publishing houses, such as Norstedts, Massolit, and B. Wahlstrom, focusing on both adult and children's literature. The company has expanded its services internationally, with operations in countries like Denmark, Norway, the Netherlands, and the USA, positioning itself as a prominent player in the subscription-based audiobook and e-book market.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

PRO Unlimited Inc. specializes in contingent workforce management solutions for Global and Fortune 500 companies. Founded in 1991 and headquartered in Boca Raton, Florida, the company addresses the growing need for effective management of temporary and independent labor. Its services include a vendor-neutral Managed Services Program that oversees the procurement and engagement of contingent workers, a Vendor Management System (VMS) that centralizes various aspects of workforce management, and RatePoint, a SaaS application providing hiring intelligence for contingent positions. These solutions assist clients in navigating challenges related to supplier management, worker classification, lifecycle tracking, and compliance. With additional locations in the United Kingdom, Japan, California, New York, and Hong Kong, PRO Unlimited aims to enhance operational efficiency and reduce costs for organizations relying on a flexible workforce.

Mollie is a payments platform based in Amsterdam, founded in 2004, that simplifies the integration of payment solutions for online businesses. Serving over 50,000 clients, the company supports a variety of local payment methods, including Mastercard, VISA, PayPal, and iDEAL, among others. Mollie's technology-driven approach allows merchants to easily implement payment systems through a simple yet powerful API, facilitating one-click payments, fraud monitoring, and real-time accounting. By streamlining the payment process, Mollie enables businesses to efficiently manage their finances and enhance revenue generation while minimizing operational complexities.

Parcel2Go is a leading online parcel delivery service based in the UK, offering a comprehensive range of courier services for both home and business users. The company operates a parcel delivery comparison platform that provides customers with an alternative to traditional postal services. By partnering with major courier companies such as FedEx, UPS, and Hermes, Parcel2Go enables users to send packages of various sizes to destinations domestically and internationally. The platform allows customers to manage their orders online and track their shipments, ensuring a convenient and cost-effective delivery experience.

Solarpack is an independent solar photovoltaic power producer that specializes in the development and operation of large-scale solar projects. Established in 2005 and headquartered in Getxo, Vizcaya, Spain, the company offers a comprehensive range of services, including financing, construction, and management of utility-scale solar plants. With a total operational capacity of 160 MW across 13 plants and asset management services for an additional 302 MW, Solarpack has a diversified geographical presence, employing over 140 people in 10 countries. The company aims to contribute to sustainable energy infrastructure while fostering social development within the communities it serves by creating economic value and promoting quality employment through its initiatives.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Molslinjen is a privately held company that provides ferry services between Jutland and the island of Zealand in Denmark. The company operates a fleet of catamaran ferries designed for efficient marine transportation, allowing for easy boarding and disembarking of passengers, cars, trucks, and buses. This service aims to offer fast and comfortable travel options, supporting both domestic transportation needs and enhancing connectivity between regions.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Idealista operates an online property portal that serves agents and private individuals in Spain, Italy, and Portugal. The platform functions as a digital real estate marketplace, providing buyers and sellers with essential real-time information to facilitate property transactions. By offering a user-friendly interface, Idealista helps alleviate the challenges associated with finding a home, thus supporting millions of users in their real estate endeavors. Additionally, the company allows property owners to advertise their listings through a subscription model, enabling them to reach a broader audience while accessing valuable market insights.

Colisée is a key player in the global health care and old-age dependency sector, and has developed a real expertise in elderly people care and well-being. Its network includes 90 facilities in France, Italy and Spain and close to 70 home-based services agencies in France. In those two business segments, Colisée employs more than 6,700 people.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder, and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands, and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on Twitter, LinkedIn, YouTube, and Instagram.

Freepik is a digital platform based in Málaga, Spain, specializing in providing designers and creative professionals with access to a vast library of graphic resources. Established in 2010, Freepik has evolved into a comprehensive content creation tool, integrating advanced generative AI technology to streamline the production of high-quality audiovisual content. The platform caters to a diverse user base, including designers, photographers, architects, and advertisers, offering various assets such as illustrations, photos, icons, and presentation templates. With over 100 million users and nearly 800,000 subscribers, Freepik combines its extensive stock content library with AI-driven tools that simplify and enhance the creative process. By continuously innovating and adapting to new design trends, Freepik redefines the landscape of digital creativity, making it easier for users to generate, refine, and optimize visuals efficiently.

Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, the Netherlands, specializing in cell-based immunotherapy products aimed at treating blood cancers and inherited blood disorders. The company is currently advancing K-NK002, which is undergoing Phase II clinical trials for blood cancer patients receiving haploidentical hematopoietic stem cell transplants with the post-transplant cyclophosphamide protocol. Additionally, Kiadis Pharma is developing K-NK003, currently in Phase I/II trials for patients with acute myeloid leukemia relapse or refractory cases. The preclinical product pipeline includes K-NK00X, a natural killer (NK) cell therapy candidate targeting various solid tumors. Kiadis Pharma also collaborates with several institutions, including Harbour BioMed and Erasmus Medical Center, to explore a combination of monoclonal antibodies and natural killer cells as a potential treatment for COVID-19. Founded in 1997, Kiadis Pharma is committed to addressing significant unmet medical needs in the treatment of blood-related conditions.

FoRx Therapeutics AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company specializes in the development of innovative therapeutics for cancer treatment, specifically targeting key molecular pathways involved in DNA replication stress. By focusing on these novel pathways, FoRx Therapeutics aims to create first-in-class compounds that offer a new approach to targeted anticancer therapies. Through its research and development efforts, the company seeks to provide effective solutions in the fight against cancer.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Snipr Biome ApS is a biotechnology company based in Copenhagen, Denmark, focusing on the development of CRISPR technology for the treatment of microbial diseases. Established in 2017, the company aims to revolutionize how such diseases are addressed by leveraging the adaptive immune system to create medicines that selectively target and eliminate harmful bacteria based on their specific DNA sequences. By utilizing a novel approach that subverts elements of the endogenous bacterial CRISPR machinery, Snipr Biome provides health professionals with innovative tools for targeted microbiome engineering, enhancing the precision and effectiveness of treatments for bacterial infections.

WS Audiology A/S was formed in 2019 through the partnership of Singapore-headquartered Sivantos and Lynge/Denmark-based Widex. Two pioneers joining forces with one clear ambition: to expand hearing care for the millions of people with hearing needs.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

Veritas Petroleum Services is a global provider of testing, inspection, and advisory services, operating five laboratories strategically located in the Netherlands, Singapore, Houston, Fujairah, and Manchester. The company specializes in fuel quality testing, bunker quantity surveys, oil condition monitoring, and transformer oil testing, among other services. By offering these solutions, Veritas Petroleum Services assists clients in the marine, power, and renewable sectors to optimize their operational performance. The company focuses on helping its customers improve fuel management, reduce fuel costs, enhance operational efficiency, and comply with environmental regulations.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2015, the company is dedicated to creating first-in-class therapies aimed at selectively killing cancer cells. Artios's product pipeline features several promising programs, including a focus on DNA polymerase theta (Polθ), which plays a crucial role in DNA repair processes. Additionally, the company is advancing an in-licensed program that targets a newly identified protein linked to DDR and is developing a novel treatment aimed at DNA nucleases involved in these pathways. Artios collaborates with Cancer Research Technology and prominent DNA repair researchers globally to enhance its research and development efforts.

SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.

Azelis Group is a specialty chemicals distributor and innovation service provider that caters to the specialty chemicals and food ingredients industries. The company operates through several geographic segments, including EMEA, which encompasses Europe, the Middle East, and Africa; the Americas, which includes the United States, Canada, Mexico, and parts of South America; and Asia-Pacific, covering various countries in Asia and the Pacific region. Azelis leverages its extensive local knowledge and an international structure to offer a diverse range of products and services. The company emphasizes high levels of technical support and customized solutions to meet the specific needs of its clients. Its operations are supported by a corporate service center and headquarters located in Belgium.

MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

BBS Automation GmbH is a provider of automation solutions and engineering services, specializing in the design, development, manufacturing, and installation of automated assembly and testing systems. The company serves a diverse range of industries, including automotive, aerospace, life sciences, consumer goods, electronic devices, energy storage, and renewable energy. BBS Automation also offers leak detection, build-to-print services, and winding technology solutions, along with training and after-sales support. With nearly 550 employees, the company operates production sites in Germany, China, Malaysia, and the United States, partnering with prominent global clients. Founded in 1891 and headquartered in Garching bei München, Germany, BBS Automation is committed to delivering flexible and high-quality automation solutions for complex manufacturing and testing processes.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.

Orphazyme is a Copenhagen-based biopharmaceutical company focused on developing innovative therapies for lysosomal storage diseases, which are serious genetic disorders. Founded on scientific discoveries from the academic work of Professor Marja Jäättela and Thomas Kirkegaard Jensen at the Danish Cancer Society, Orphazyme collaborates with leading academic institutions across Europe and the United States. The company is actively engaged in biopharmaceutical research and development, and it has entered into a strategic partnership with CombiGene AB to advance its objectives in this field.

Caiway is a telecommunications infrastructure company based in the Netherlands, specializing in broadband services for over 350,000 households and businesses. The company has expanded its fiber network into remote areas, enhancing connectivity for municipalities and homes. As a regional internet service provider, Caiway offers a variety of services, including broadband, television, and telephony, delivered through its cable and fiber infrastructure. Major regions within Caiway's operational footprint include Westland, Schiedam, and Almelo, where it aims to provide reliable networking and high-quality service to its customers.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

DentConnect is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. DentConnect is headquartered in the Netherlands and serves over one million patients through its pan-European network of over 220 clinics. DentConnect acts as a multi-functional service organization for these clinics, allowing the dentists to fully focus on providing patients with the best possible care. DentConnect Shared Service Center supports and facilitates dentists with HR, Finance and administration, quality and care management, procurement, marketing and communication and general management.

Two modern and strategically located office buildings in suburban Frankfurt.

Simplify Medical, Inc. is a medical device company that specializes in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs for spinal use. Notably, it offers the Simplify Disc, a non-metallic cervical artificial disc that is MRI-compatible, allowing for comprehensive diagnostic imaging while eliminating the need for CT scans. This product addresses single-level symptomatic cervical disc disease and is aimed at skeletally mature patients requiring reconstruction following discectomy. Founded in 2013 and based in Sunnyvale, California, the company markets its products through distributors in various international markets, including the United Kingdom and Germany. Simplify Medical is committed to minimizing patient exposure to radiation and preserving the natural range of motion in the spine with its innovative artificial disc technology.

Open Systems AG is a provider of managed security services, focusing on secure connectivity for global enterprises, non-governmental organizations, and various institutions. Founded in 1990 and headquartered in Zurich, Switzerland, with additional offices in Sydney and New York, the company specializes in a wide range of services, including network security, application delivery, identity management, and global connectivity. Their offerings encompass distributed and enterprise firewalls, WAN encryption, network security monitoring, and intrusion prevention systems. Open Systems also provides web application firewalls, email gateways, traffic shaping, and identity management solutions. The company serves multiple sectors, including government, media, finance, healthcare, infrastructure, logistics, manufacturing, and retail, ensuring comprehensive security and monitoring for critical business applications and IT networks.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.

Innovyze is a global provider of software solutions focused on wet infrastructure business analytics, catering to the technological needs of water and wastewater utilities, government agencies, and engineering organizations. The company serves a diverse clientele, including major cities and foremost utilities across the UK, Australia, East Asia, and North America, as well as top-rated design firms worldwide. With a strong presence in North America, Europe, and the Asia Pacific, Innovyze offers a connected portfolio of advanced products that empower engineers to effectively plan, manage, design, protect, operate, and sustain efficient and reliable water infrastructure systems. This comprehensive approach ensures that its clients can achieve optimal performance and enduring success in their operations.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Adamo is a telecom operator in Spain offering ultra high speed Internet via Fiber To The Home across Spain (Catalonia, Valencia, , Madrid, Andalucia...). We offer the highest speed in Spain, 1000 Mbit/s Internet access and our origin is Swedish. Coverage: Alicante, Almería, Asturias, Badajoz, Barcelona, Burgos, Cantabria, Castellón, Córdoba, Cuenca, Gerona, Granada, Guadalajara, Lérida, Lugo, Madrid, Navarra, Palencia, Sevilla, Tarragona, Toledo, Valencia, Valladolid & Vizcaya.

GlobalConnect is a prominent provider of fiber network, data center, and managed hosting services in Northern Europe, particularly Denmark and Germany. Founded in 1998 by Niels Zibrandtsen, the company operates an extensive optical fiber network spanning 12,500 kilometers and offers approximately 13,000 square meters of data center space. GlobalConnect delivers a range of services, including bandwidth connectivity, colocation, cloud infrastructure, and managed hosting, catering to both enterprises and consumers. With a workforce of over 200 employees, the company aims to enhance connectivity and support businesses in achieving efficient networking solutions.

IVC is the privately owned vet services platform in the UK with more than 290 sites and an online pet pharmacy. IVC employs approximately 2,700 FTEs, including 800+ FTE veterinarians.

Based in Vejle, Denmark, Fertin Pharma offers innovative, high-quality pharmaceutical and nutraceutical chewing gum products. Through partnerships with leading global pharma companies, we have consolidated our position as the preferred B2B partner for nicotine chewing gum. As a family-owned company with a unique heritage in chewing gum, we excel in every part of the development and manufacturing processes. We value an open, committed and professional relationship with our collaborators and when partnering with Fertin Pharma, you will experience a company dedicated to the field of medicated chewing gum.

Dojo is a financial technology company specializing in card payment solutions for small and medium-sized businesses in the UK and Ireland. The company offers a range of services including contactless card machines, online payment systems, and integrated payment solutions, enabling over 100,000 businesses to accept payments in-store, online, over the phone, and on the go. Established in London, Dojo focuses on providing user-friendly and flexible payment options to enhance the transaction experience for both merchants and customers.

CHEP is a leading global provider of supply chain solutions, specializing in enhancing efficiency and sustainability for its customers. The company offers a range of services, including asset management and repair for unit load devices (ULDs), galley carts, and ground support equipment through its CHEP Aerospace Solutions division, headquartered in Zurich, Switzerland. This division manages the world's largest independent fleet of ULDs and operates a comprehensive global network for the maintenance and repair of containers, pallets, and inflight food service equipment. By providing tailor-made outsourcing solutions, CHEP enables airlines to focus on their core operations of transporting passengers and cargo while achieving significant cost savings and operational benefits. The company serves over 80 airlines worldwide, leveraging its unique capabilities and insights to help clients improve their logistics and supply chain management.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

Kuoni Reisen Holding AG is a Switzerland-based company that serves the travel industry and government sectors through three primary business activities. It operates Global Travel Distribution (GTD), which supplies hotel accommodations and destination services to travel companies and agents. The company also offers Global Travel Services (GTS), which coordinates comprehensive destination management services, including accommodation, transportation, tours, and event management. Additionally, Kuoni provides Visa Facilitation Services (VFS) through numerous application centers worldwide, assisting with visa outsourcing. The company further enhances its portfolio with Kuoni Destination Management, specializing in event development, budgeting, and creative direction, as well as providing entertainment and AV technology solutions for various events. This diverse range of services underscores Kuoni's commitment to delivering innovative and comprehensive travel and event solutions.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

kfzteile24 GmbH is a German retailer specializing in automotive spare parts and accessories, operating primarily online through its platforms www.kfzteile24.de and www.autoteile24.de. Founded in 2001 and headquartered in Berlin, the company has established itself as one of the largest online auto parts retailers in Germany, achieving significant sales growth over the years. In addition to its online presence, kfzteile24 operates three physical retail stores that are affiliated with repair shops, enhancing its service offerings. The company provides a wide range of automotive products, including exhaust systems, batteries, and braking systems, and features a vehicle selection tool that facilitates the quick identification of required parts. Customers also benefit from in-house support from automotive experts who assist in finding suitable replacement parts at competitive prices.

Kuros Biosciences AG is a Swiss biopharmaceutical company dedicated to developing innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has created a diverse pipeline leveraging proprietary technologies. The company specializes in biopharmaceutical products aimed at treating chronic diseases, focusing on sealants and orthobiologics. Its sealant product, Neuroseal, is under review for CE marking in the EU, while its orthobiologics offerings include MagnetOs Granules and MagnetOs Putty, approved for orthopedic and dental use in both the EU and the US. Kuros also has advanced clinical programs, with products like KUR-111 and KUR-113 having completed Phase II trials for bone fractures. Collaborations, such as with Checkmate Pharmaceuticals, further enhance its oncology treatment development. With its operational base in Schlieren, Switzerland, Kuros is transitioning to a commercial stage, aiming for broader market reach in key therapeutic areas.

HusCompagniet is a market leader in Denmark and rapidly growing positions in Germany and Sweden. HusCompagniet builds on a strong brand and business model, delivering high quality single-family houses with great value for money. By taking large market shares in recent years, the Company is now three times larger than the nearest competitor on the Danish market. In 2014, HusCompagniet delivered 1,010 houses to customers in Denmark, Sweden and Germany. The revenue has grown from DKK 1.2 billion in 2011 to DKK 1.8 billion in 2014. The company employs 230 people. HusCompagniet have been awarded House Builder of the Year in Denmark the last three years.

Neuravi Limited, founded in 2009 and headquartered in Galway, Ireland, specializes in the design and development of innovative clot retrieval devices aimed at restoring blood flow in patients experiencing ischemic strokes caused by arterial blockages in the brain. The company's primary product, the EmboTrap revascularization device, is utilized in the treatment of acute ischemic strokes and is available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Neuravi's focus on neuro-interventional therapies is backed by extensive research into the mechanisms of stroke, particularly regarding the capture and removal of clots, which enhances treatment efficacy and improves patient outcomes. The company collaborates with international researchers and clinicians to foster the development of new solutions for this critical medical challenge. As of April 2017, Neuravi operates as a subsidiary of DePuy Ireland Unlimited Company.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Evidensia Djursjukvård AB owns and operates veterinary hospitals and clinics in Sweden, Norway, Denmark, Finland, Holland, Germany, and Switzerland.

TIA Technology is a prominent developer of software systems tailored for the insurance industry, based in Denmark. The company provides a versatile and comprehensive suite of core applications specifically designed for property, casualty, and composite insurers. In addition to its primary focus on property and casualty insurance, TIA Technology also offers solutions for life and pension, health insurance, and various extension modules. Furthermore, the company delivers extensive implementation, application management, and hosting services, which support insurers in executing their digital and business strategies effectively.

TIA Technology is a prominent developer of software systems tailored for the insurance industry, based in Denmark. The company provides a versatile and comprehensive suite of core applications specifically designed for property, casualty, and composite insurers. In addition to its primary focus on property and casualty insurance, TIA Technology also offers solutions for life and pension, health insurance, and various extension modules. Furthermore, the company delivers extensive implementation, application management, and hosting services, which support insurers in executing their digital and business strategies effectively.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Charleston Holding is an operator of nursing homes and residential care facilities in Germany, focused on serving physically and mentally impaired residents. The company adopts a buy-and-build strategy within the nursing home market, aiming to enhance its portfolio through acquisitions. Charleston provides a range of services, including nursing care, preventative care, and intensive care, along with assisted living and daycare options. By offering these services, Charleston Holding seeks to improve the quality of life for its residents and support their well-being into old age.

Faerch Plast is a Danish packaging company that holds a position within rigid plastic packaging for the food industry. The company has over 40 years of experience in developing, designing and producing innovative and high-quality packaging for the ready meal, “food-to-go” and fresh meat markets.

Flying Tiger Copenhagen is a design retail store based in Copenhagen, Denmark, known for its unique and whimsical selection of own-designed products at affordable prices. The company operates both physical retail outlets and online stores, offering a diverse range of items including home accessories, kitchenware, office supplies, school materials, holiday decorations, toys, and garden products. With locations around the globe, Flying Tiger Copenhagen aims to provide customers with creative and practical solutions for everyday needs while maintaining competitive pricing. The store's inventory is continually updated, ensuring a fresh and engaging shopping experience.

Kiadis Pharma N.V. is a biopharmaceutical company based in Amsterdam, the Netherlands, specializing in cell-based immunotherapy products aimed at treating blood cancers and inherited blood disorders. The company is currently advancing K-NK002, which is undergoing Phase II clinical trials for blood cancer patients receiving haploidentical hematopoietic stem cell transplants with the post-transplant cyclophosphamide protocol. Additionally, Kiadis Pharma is developing K-NK003, currently in Phase I/II trials for patients with acute myeloid leukemia relapse or refractory cases. The preclinical product pipeline includes K-NK00X, a natural killer (NK) cell therapy candidate targeting various solid tumors. Kiadis Pharma also collaborates with several institutions, including Harbour BioMed and Erasmus Medical Center, to explore a combination of monoclonal antibodies and natural killer cells as a potential treatment for COVID-19. Founded in 1997, Kiadis Pharma is committed to addressing significant unmet medical needs in the treatment of blood-related conditions.

Internetstores GmbH is an online retailer based in Esslingen, Germany, specializing in bicycles and outdoor products. Founded in 2003, the company operates both online and physical retail stores across Germany, Sweden, and France. It offers a diverse range of products, including bicycles, sportswear, bike parts and accessories, as well as outdoor adventure gear, camping equipment, and clothing. Internetstores caters to a wide audience, from beginner cyclists to families and hobby athletes, providing a variety of multi-brand options to enhance outdoor exploration. The company also has additional locations in Stuttgart, Berlin, Lyon, and Stockholm, and operates as a subsidiary of Signa Retail GmbH.

Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.

Vivoryon Therapeutics AG is a clinical-stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products aimed at treating Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has successfully completed Phase IIb clinical trials for Alzheimer's treatment. Additionally, Vivoryon is advancing PQ1565, another small molecule targeting cancer, and is developing a monoclonal antibody to enhance the clearance of toxic pyroglutamate-Abeta (pGlu-Abeta). The company has established research collaborations with University Medical Center Schleswig-Holstein, Nordic Bioscience, and the Fraunhofer Institute, focusing on cancer immunotherapy and the clinical development of its candidates. Founded in 1997 and originally named Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

United Digital Group is focused on providing businesses with digitalization strategies and branding solutions. United Digital Group provides their customers with consulting services; analytics and redesigning services for business applications; brand management solutions; and e-learning services. United Digital Group was founded by Michael Riese in 1999. It is based in Hamburg, Germany.

Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.